Curis
CRIS
#10341
Rank
NZ$31.93 M
Marketcap
NZ$0.82
Share price
-2.08%
Change (1 day)
-76.64%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -NZ$56.22 Million

According to Curis's latest financial reports the company's current earnings are NZ$11.65 Million. In 2024 the company made an earning of -NZ$73.02 Million, an increase over its 2023 earnings that were of -NZ$77.49 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$56.22 Million-23.01%
2024 -NZ$73.02 Million-5.77%
2023 -NZ$77.49 Million-13.1%
2022 -NZ$89.17 Million27.52%
2021 -NZ$69.93 Million65.09%
2020 -NZ$42.36 Million-9.1%
2019 -NZ$46.6 Million-4.73%
2018 -NZ$48.91 Million-41.95%
2017 -NZ$84.25 Million-14.37%
2016 -NZ$98.39 Million3.55%
2015 -NZ$95.01 Million271.52%
2014 -NZ$25.58 Million76.64%
2013 -NZ$14.48 Million
2011 -NZ$12.3 Million27.76%
2010 -NZ$9.63 Million-43.87%
2009 -NZ$17.15 Million-23.44%
2008 -NZ$22.4 Million56.66%
2007 -NZ$14.3 Million-16.71%
2006 -NZ$17.17 Million-36.92%
2005 -NZ$27.21 Million156.25%
2004 -NZ$10.62 Million-37.24%
2003 -NZ$16.92 Million-93.34%
2002 -NZ$0.26 Billion86.79%
2001 -NZ$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$18.07 B-32,629.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.38 B-29,576.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-NZ$0.11 Billion 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$1.71 B-3,181.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.5 Billion 782.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-NZ$42.27 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.28 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA